Immunological and molecular correlates of disease recurrence after liver resection for hepatocellular carcinoma.
The definition of the risk of hepatocellular carcinoma (HCC) recurrence after resection represents a central issue to improve the clinical management of patients. In this study we examined the prognostic relevance of infiltrating immune cell subsets in the tumor (TIL) and in nontumorous (NT) liver (...
Guardado en:
Autores principales: | Elisabetta Cariani, Massimo Pilli, Alessandro Zerbini, Cristina Rota, Andrea Olivani, Guido Pelosi, Claudia Schianchi, Paolo Soliani, Nicoletta Campanini, Enrico Maria Silini, Tommaso Trenti, Carlo Ferrari, Gabriele Missale |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ce40c29676b6456492e107d17b9532b0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection.
por: Jonas Söderholm, et al.
Publicado: (2013) -
Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertension.
por: Jian-Hong Zhong, et al.
Publicado: (2014) -
Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine
por: Federica Vernuccio, et al.
Publicado: (2021) -
Prediction of early recurrence and response to adjuvant Sorafenib for hepatocellular carcinoma after resection
por: Liming Zheng, et al.
Publicado: (2021) -
Genome-wide identification and characterization of circular RNA in resected hepatocellular carcinoma and background liver tissue
por: Yuki Sunagawa, et al.
Publicado: (2021)